Clinical trials
Emphysema trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2009 | 2 |
| 2011 | 5 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Terminated | 6 |
| Recruiting | 5 |
| Unknown status | 3 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boston Scientific Corporation | 4 |
| Aeris Therapeutics | 3 |
| Pulmonx Corporation | 3 |
| GlaxoSmithKline | 2 |
| University Hospital, Bordeaux | 2 |
| University Hospital, Lille | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| AstraZeneca | 1 |
| CHU de Reims | 1 |
| Eli Lilly and Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Emphysema | 27 |
| Pulmonary Disease, Chronic Obstructive | 18 |
| Lung Diseases | 5 |
| Bronchitis, Chronic | 3 |
| Pulmonary Emphysema | 3 |
| Respiratory Tract Diseases | 3 |
| Respiratory Aspiration | 2 |
| alpha 1-Antitrypsin Deficiency | 2 |
| Asthma | 1 |
| Bronchiolitis Obliterans Syndrome | 1 |
Trials
Showing 76 to 27 of 27. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.